Assessing a patient’s understanding of his or her own illness is important as cancer treatments become more and more complex, said Denalee O’Malley, PhD, LSW, instructor, Department of Family Medicine and Community Health, Rutgers Robert Wood Johnson Medical School.
Assessing a patient’s understanding of his or her own illness is important as cancer treatments become more and more complex, said Denalee O’Malley, PhD, LSW, instructor, Department of Family Medicine and Community Health, Rutgers Robert Wood Johnson Medical School.
Transcript
What gaps do caregivers and patients face trying to access and understand health information during treatment and post-treatment? How can oncologists and primary care physicians ensure that health literacy issues are resolved, so patients are informed about their options?
This is a this is a really tricky issue, because [as] treatments become more and more complicated, it … can be very time consuming and complex to communicate treatment options, but also risk in a way that people understand that.
So, I think it’s really important to assess what a patient understands about their illness. Also, what they understand about the goals of their treatment—is everyone on the same page as to what the actual goal of the treatment is? And also, what are the practicalities—do they understand what they need in that environment to manage that? Do they have the practical issues covered financially to be able to get the resources they need to manage the day-to-day issues getting to and from treatment?
I think that not only do we need to asses it from a health literacy perspective, but also helping patients to make sense of what this means to them in their world—do they accommodate it without help and do they need help and are there people on the healthcare team who can assist them so that they can have the optimal treatment outcome.
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More